Research Advances in Abdominal Aortic Aneurysms: Triglyceride-Rich Lipoproteins as a Therapeutic Target.

[1]  J. Pankow,et al.  Genome-wide association meta-analysis identifies risk loci for abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target , 2023, Nature Genetics.

[2]  J. Rabinowitz,et al.  Spatially resolved isotope tracing reveals tissue metabolic activity , 2022, Nature Methods.

[3]  Baohui Xu,et al.  No Effect of Hypercholesterolemia on Elastase-Induced Experimental Abdominal Aortic Aneurysm Progression , 2021, Biomolecules.

[4]  J. Golledge,et al.  Mouse models for abdominal aortic aneurysm , 2020, British journal of pharmacology.

[5]  A. Daugherty,et al.  Hypercholesterolemia Accelerates Both the Initiation and Progression of Angiotensin II-induced Abdominal Aortic Aneurysms , 2020, bioRxiv.

[6]  Tanya M. Teslovich,et al.  Genetics of Blood Lipids Among ~300,000 Multi-Ethnic Participants of the Million Veteran Program , 2018, Nature Genetics.

[7]  N. Roetker,et al.  Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study , 2018, PloS one.

[8]  N. Samani,et al.  Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm , 2017, JAMA cardiology.

[9]  B. Taylor,et al.  Multicentre study of abdominal aortic aneurysm measurement and enlargement , 2015, The British journal of surgery.

[10]  J. Lindholt,et al.  Statin use and rupture of abdominal aortic aneurysm , 2014, The British journal of surgery.

[11]  F. Moll,et al.  Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[12]  J. Golledge,et al.  Association of statin prescription with small abdominal aortic aneurysm progression. , 2010, American heart journal.

[13]  K. Shimada,et al.  Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. , 2009, Atherosclerosis.

[14]  J. Powell,et al.  Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  M. Björck,et al.  Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. , 2005, Journal of vascular surgery.

[16]  N. Day,et al.  LDL cholesterol is associated with small abdominal aortic aneurysms. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  M. Law,et al.  Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm. , 1998, International journal of epidemiology.

[18]  L. Mazzolai,et al.  Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins. , 2012, VASA. Zeitschrift fur Gefasskrankheiten.

[19]  H. Takagi,et al.  Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  I. Chetter,et al.  A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. , 2011, Annals of vascular surgery.

[21]  E. Choke,et al.  A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.